Cargando…
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database
PURPOSE: The Time to First Metastatic Recurrence (TFMR) could be considered as an indirect reflection of the tumour growth kinetics which plays an important role in cancer. Molecular subtypes such as expression of estrogen receptor are known predictive factors of TFMR. The CinéBreast study aimed to...
Autores principales: | Gougis, P., Carton, M., Tchokothe, C., Campone, M., Dalenc, F., Mailliez, A., Levy, C., Jacot, W., Debled, M., Leheurteur, M., Bachelot, T., Hennequin, A., Perrin, C., Gonçalves, A., Uwer, L., Eymard, J.C., Petit, T., Mouret-Reynier, M.A., Chamorey, E., Simon, G., Saghatchian, M., Cailliot, C., Le Tourneau, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375625/ https://www.ncbi.nlm.nih.gov/pubmed/31675683 http://dx.doi.org/10.1016/j.breast.2019.10.004 |
Ejemplares similares
-
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)
por: Pérol, David, et al.
Publicado: (2019) -
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program
por: Cabel, Luc, et al.
Publicado: (2021) -
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort
por: Frank, Sophie, et al.
Publicado: (2020) -
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
por: Grinda, T., et al.
Publicado: (2021) -
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)
por: Dano, D., et al.
Publicado: (2021)